← Open Payments lookup

PHILLIP BANKSTON: Open Payments

NPI 1518453695 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$684 in 29 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $750 · 2025 $684

Food & beverage: $684
CompanyPaymentsAmount
Tris Pharma Inc5$168
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$113
ABBVIE INC.4$105
Corium, LLC4$84
Neurocrine BioSciences, Inc.3$70
Collegium Pharmaceutical, Inc.4$68
Alkermes, Inc.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$19
Supernus Pharmaceuticals, Inc.1$17
Janssen Pharmaceuticals, Inc1$17

Products named: Dyanavel XR, CAPLYTA, VRAYLAR, Azstarys, INGREZZA, Jornay PM, ARISTADA, TRINTELLIX.

Industry payments across CO — which companies pay providers there.